Abiopharma

argenx to Present at 44th Annual J.P. Morgan Healthcare Conference

PMGC Holdings Inc. Announces Reverse Stock Split Effective January 6, 2026

Biologics License Application for Subcutaneous Formulation of “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease Accepted in China

Natera - Natera Presents Updated Analyses From ALTAIR Clinical Trial at ASCO GI

Natera Presents Updated Analyses From ALTAIR Clinical Trial at ASCO GI

ResMed Inc. Daily Stock Update

Westlake refuerza su cartera global de soluciones de compuestos con la adquisición del negocio de soluciones de formulación de compuestos de ACI

QURE Investigation: Investors Encouraged to Contact Kirby McInerney LLP

ALVO Investigation: Investors Encouraged to Contact Kirby McInerney LLP

New SEC Form for ResMed Inc.